BlackRock Fund Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
KKRC
BA
GGHC
BlackRock Fund Advisors's AMED Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Amedisys (AMED) stake by 14% in Q4 2016, buying an estimated $12.5M and bringing the position to 2,326,240 shares worth $99.2M. The position accounts for 0.02% of the portfolio, ranked #1200.
BlackRock Fund Advisors first reported a position in AMED in Q2 2013 and has held it in 15 quarters since. 159 funds tracked by Wall St. Rank hold AMED as of Q4 2016.
- BlackRock Fund Advisors held 2,326,240 shares of Amedisys worth $99.2M as of Q4 2016.
- BlackRock Fund Advisors bought 293,926 Amedisys shares in Q4 2016, an estimated $12.5M.
- Amedisys made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1200 holding.
- BlackRock Fund Advisors first reported a position in Amedisys in Q2 2013 and has held it in 15 quarters since.
- 159 funds tracked by Wall St. Rank held Amedisys as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.